{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:14:04Z","timestamp":1787242444567,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","award":["2013-544"],"award-info":[{"award-number":["2013-544"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503562"],"award-info":[{"award-number":["81503562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202006940001"],"award-info":[{"award-number":["202006940001"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.clcc.2022.10.007","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T10:17:23Z","timestamp":1668161843000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"Huaqiang","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongguo","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sandstr\u00f6m","family":"Gerdtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuchen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2022.10.007_bib0001","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.pan.2017.07.002","article-title":"Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care","volume":"17","author":"Ouyang","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.clcc.2022.10.007_bib0002","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clcc.2022.10.007_bib0003","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clcc.2022.10.007_bib0004","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial","volume":"387","author":"Wang-Gillam","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2022.10.007_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clcc.2022.10.007_bib0006","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1200\/JCO.2012.43.3680","article-title":"Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study","volume":"31","author":"Ueno","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.10.007_bib0007","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.clcc.2022.10.007_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033452","article-title":"Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1)","volume":"9","author":"Wei","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clcc.2022.10.007_bib0009","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/MPA.0b013e318220e5b9","article-title":"Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival","volume":"40","author":"Azizi","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.10.007_bib0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MPA.0000000000001822","article-title":"Liver metastasis-directed ablative radiotherapy in pancreatic cancer offers prolonged time off systemic therapy in selected patients: data from a multi-institutional retrospective study","volume":"50","author":"Lee","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.10.007_bib0011","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12885-016-2552-2","article-title":"Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcinoma: a single center experience","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2022.10.007_bib0012","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.pan.2018.09.015","article-title":"Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases","volume":"18","author":"Ouyang","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.clcc.2022.10.007_bib0013","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2009.09.004","article-title":"Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial","volume":"51","author":"Okusaka","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clcc.2022.10.007_bib0014","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.10.007_bib0015","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","article-title":"Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer","volume":"23","author":"Ducreux","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.10.007_bib0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/cancers14010057","article-title":"Survival benefit of resection surgery for pancreatic ductal adenocarcinoma with liver metastases: a propensity score-matched SEER database analysis","volume":"14","author":"Pausch","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2022.10.007_bib0017","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amsu.2020.11.037","article-title":"Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - a case-control study","volume":"62","author":"Shao","year":"2020","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.clcc.2022.10.007_bib0018","article-title":"Hepatic artery infusion of floxuridine in combination with systemic chemotherapy for pancreatic cancer liver metastasis: a propensity score-matched analysis in two centers","volume":"11","author":"Peng","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.clcc.2022.10.007_bib0019","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1186\/s12885-021-08943-w","article-title":"Nomogram to predict survival of patients with advanced and metastatic pancreatic cancer","volume":"21","author":"Deng","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2022.10.007_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/CBM-210190","article-title":"Development and validation of a radiomics nomogram to discriminate advanced pancreatic cancer with liver metastases or other metastatic patterns","volume":"32","author":"Zhang","year":"2021","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.clcc.2022.10.007_bib0021","doi-asserted-by":"crossref","first-page":"8934","DOI":"10.1002\/cam4.4415","article-title":"Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma","volume":"10","author":"Yu","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.clcc.2022.10.007_bib0022","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MPA.0000000000001857","article-title":"Incidence, treatment, and survival of synchronous peritoneal metastases in pancreatic cancer: update of a nationwide cohort","volume":"50","author":"Rijken","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.clcc.2022.10.007_bib0023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/1354750X.2021.1893814","article-title":"Readily available biomarkers predict poor survival in metastatic pancreatic cancer","volume":"26","author":"Strijker","year":"2021","journal-title":"Biomarkers"},{"key":"10.1016\/j.clcc.2022.10.007_bib0024","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pan.2017.11.014","article-title":"Transarterial chemoembolization in pancreatic adenocarcinoma with liver metastases: MR-based tumor response evaluation, apparent diffusion coefficient (ADC) patterns, and survival rates","volume":"18","author":"Vogl","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.clcc.2022.10.007_bib0025","doi-asserted-by":"crossref","first-page":"39746","DOI":"10.18632\/oncotarget.14642","article-title":"Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:09:19Z","timestamp":1761520159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002822001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1533002822001219"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2022.10.007","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2022.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}